Search research articles
Contact Us
Filters
Showing results (71-80 of 192) with videos related to
Page
of 20
Sort By:
Cancers
|
September 9, 2023
Role of YY1 in the Regulation of Anti-Apoptotic Gene Products in Drug-Resistant Cancer Cells
Megan Jung, Indy Bui, Benjamin Bonavida
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 28, 2025
PCO25-215: The RKIP-HER2 Axis in Breast Cancer and Role in Immune Evasion
Ania Khachikian, Mai Ho, Benjamin Bonavida
Journal of Experimental & Clinical Cancer Research : CR
|
May 27, 2016
Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication
Samantha Kaufhold, Hermes Garbán, Benjamin Bonavida
International Journal of Oncology
|
July 3, 2010
Prognostic significance of second mitochondria-derived activator of caspase (Smac/DIABLO) expression in bladder cancer and target for therapy
Yoichi Mizutani, Yoji Katsuoka, Benjamin Bonavida
Biochimica Et Biophysica Acta. Reviews on Cancer
|
May 29, 2026
Prognostic and therapeutic significance of RKIP and YY1 in cancer, autoimmune disorders, and inflammatory pathologies
Benjamin Bonavida, Gorecki Andrzej, Libra Massimo
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
December 6, 2025
The implied dysregulated RKIP-hypoxia axis in cancer and immune evasion: Clinical implications
Ryan McWhorter, Salem Chouaib, Benjamin Bonavida
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
April 6, 2017
Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog)
SoHyun Lee, Stephanie Wottrich, Benjamin Bonavida
Critical Reviews in Immunology
|
August 4, 2021
Defective Natural Killer Cells in Melanoma: Role of NKG2D in Pathogenesis and Immunotherapy
Roni Touboul, Apostolos Zaravinos, Benjamin Bonavida
Cancers
|
June 19, 2024
Therapeutic Implications of Targeting YY1 in Glioblastoma
Inesa Navasardyan, Apostolos Zaravinos, Benjamin Bonavida
The Prostate
|
November 14, 2002
Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance
Chuen-Pei Ng, Amnon Zisman, Benjamin Bonavida
Page
of 20
Search research articles
Search
Showing results (71-80 of 192) with videos related to
Sort By:
Page
of 20
Cancers
|
September 9, 2023
Role of YY1 in the Regulation of Anti-Apoptotic Gene Products in Drug-Resistant Cancer Cells
Megan Jung, Indy Bui, Benjamin Bonavida
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 28, 2025
PCO25-215: The RKIP-HER2 Axis in Breast Cancer and Role in Immune Evasion
Ania Khachikian, Mai Ho, Benjamin Bonavida
Journal of Experimental & Clinical Cancer Research : CR
|
May 27, 2016
Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication
Samantha Kaufhold, Hermes Garbán, Benjamin Bonavida
International Journal of Oncology
|
July 3, 2010
Prognostic significance of second mitochondria-derived activator of caspase (Smac/DIABLO) expression in bladder cancer and target for therapy
Yoichi Mizutani, Yoji Katsuoka, Benjamin Bonavida
Biochimica Et Biophysica Acta. Reviews on Cancer
|
May 29, 2026
Prognostic and therapeutic significance of RKIP and YY1 in cancer, autoimmune disorders, and inflammatory pathologies
Benjamin Bonavida, Gorecki Andrzej, Libra Massimo
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
December 6, 2025
The implied dysregulated RKIP-hypoxia axis in cancer and immune evasion: Clinical implications
Ryan McWhorter, Salem Chouaib, Benjamin Bonavida
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
April 6, 2017
Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog)
SoHyun Lee, Stephanie Wottrich, Benjamin Bonavida
Critical Reviews in Immunology
|
August 4, 2021
Defective Natural Killer Cells in Melanoma: Role of NKG2D in Pathogenesis and Immunotherapy
Roni Touboul, Apostolos Zaravinos, Benjamin Bonavida
Cancers
|
June 19, 2024
Therapeutic Implications of Targeting YY1 in Glioblastoma
Inesa Navasardyan, Apostolos Zaravinos, Benjamin Bonavida
The Prostate
|
November 14, 2002
Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance
Chuen-Pei Ng, Amnon Zisman, Benjamin Bonavida
Page
of 20